Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker ResearchATLANTA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Countdown For A Cure, a foundation dedicated to accelerating mitochondrial research and medicine, today announced a $350,000 grant to Minovia Therapeutics Ltd., a clinical-stage company pioneering mitochondrial transplantation technologies. The funding will support Minovia’s research proposal to develop novel mitochondrial blood-based biomarkers that quantify mitochondrial content, quality, and function, with the goal of establishing a standardized “MitoScore.”
